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Abstract
Neuropilin tolloid-like 1 (Neto1), is a CUB domain-containing
transmembrane protein that was recently identiﬁed as a novel
component of the NMDA receptor complex. Here, we have
investigated the possible association of Neto1 with the amyloid
precursor protein (APP)695/GluN1/GluN2A and APP695/
GluN1/GluN2B NMDA receptor trafﬁcking complexes that we
have previously identiﬁed. Neto1HA was shown to co-immu-
noprecipitate with assembled NMDA receptors via GluN2A or
GluN2B subunits; Neto1HA did not co-immunoprecipitate
APP695FLAG. Co-immunoprecipitations from mammalian cells
co-transfected with APP695FLAG, Neto1HA and GluN1/GluN2A
or GluN1/GluN2B revealed that all four proteins co-exist within
one macromolecular complex. Immunoprecipitations from
native brain tissue similarly revealed the existence of a
GluN1/GluN2A or GluN2B/APP/Neto1 complex. Neto1HA
caused a reduction in the surface expression of both NMDA
receptor subtypes, but had no effect on APP695FLAG- or PSD-
95ac-Myc enhanced surface receptor expression. The Neto1
binding domain of GluN2A was mapped using GluN1/GluN2A
chimeras and GluN2A truncation constructs. The extracellular
GluN2A domain does not contribute to association with
Neto1HA but deletion of the intracellular tail resulted in a loss
of Neto-1HA co-immunoprecipitation which was paralleled by a
loss of association between GluN2A and SAP102. Thus,
Neto1 is concluded to be a component of APP/NMDA receptor
trafﬁcking complexes.
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Neuropilin tolloid-like 1 (Neto1) and Neuropilin tolloid-like 2
(Neto2) are complement C1r/C1s, Uegf, Bmp1 (CUB)
domain-containing transmembrane proteins that were recently
identiﬁed as novel components of glutamatergic neurotrans-
mitter receptor complexes. Neto1 and Neto2 have both been
described as auxiliary subunits of kainate receptors since they
were shown to alter the trafﬁcking, channel kinetics and
pharmacology of this glutamate receptor subtype in a subunit-
dependent manner (Zhang et al. 2009; Copits et al. 2011;
Straub et al. 2011a, b; Tang et al. 2011; Fisher and Mott
2012; Straub et al., 2011b). In C.elegans, SOL-1 and SOL-2,
species orthologues of Neto, were shown to be auxiliary
subunits of GLR-1, 2-amino-3-(3-hydroxy-5-methyl-iso-
xazol-4-yl)propanoic acid (AMPA) glutamatergic receptors
(Wang et al. 2012). In addition, Neto1 was shown to be a
novel component of the N-methyl-D-aspartate (NMDA)
receptor complex that was critical for maintaining the
abundance of GluN2A receptors within the post-synaptic
density (Ng et al. 2009). Neto1 was enriched in the post-
synaptic density where it was shown to co-distribute with the
scaffold protein, post-synaptic density-95 (PSD-95), and
GluN1 (Ng et al. 2009). Neto1 (/) mice were found to
have deﬁcits in long-term potentiation and NMDA receptor-
dependent spatial learning and memory (Ng et al. 2009).
We have previously shown (Cousins et al. 2009), in
agreement with Hoe et al. (2009), that amyloid precursor
protein (APP) co-immunoprecipitates with assembled GluN1/
GluN2 NMDA receptors. Over-expression of the neuronal
splice variant of APP, APP695, results in an increase in
NMDA receptor cell surface expression in cell lines (Cousins
et al. 2009). Similarly, over-expression of APP770 resulted in
an enhanced NMDA receptor expression in primary cultures
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of neuronal cells (Hoe et al. 2009). Both these ﬁndings are
compatible with an ascribed role for APP as a mediator of
neuronal trafﬁcking mechanisms possibly functioning as an
NMDA receptor auxiliary protein. Since Neto1 was reported
to be associated with NMDA receptors and crucially, to play a
role in NMDA receptor-mediated learning andmemory, it was
of interest to determine if Neto1 is a constituent of NMDA
receptor/APP macromolecular complexes. We have carried
out an investigation to determine if this is the case and we
report the ﬁndings in this article.
Experimental procedures
Constructs and antibodies
The constructs, pCISGluN1-1a, pCISGluN2A, pCISGluN2B,
pCISGluN2BFLAG and pCI-neoAPP695FLAG were as previously
described (Cik et al. 1993; Hawkins et al. 1999; Cousins et al.
2009). DNA encoding GluN2A 838-1464 was cloned into the
BamHI/EcoRI restriction enzyme sites of pcDNA4 to generate
pcDNA4GluN2A 838-1464 yielding the GluN2A C-terminal
domain with an N-terminal His tag. Note that only the GluN1-1a
splice variant was used thus pCISGluN1 and GluN1 are used
throughout the manuscript to denote the GluNR1-1a splice variant.
DNA encoding Neto1 and Neto 1-372 were cloned via EcoRV/Sal1
restriction enzyme sites of pCMV-4a to generate pCMVNeto1 and
pCMVNeto1 1-372 yielding full length Neto1 and Neto1 1-372 with
a C-terminal FLAG tag. pGW1PSD-95ac-Myc and pCMVneo-
SAP102c-Myc were kind gifts of Dr M. Sheng (Genentech Inc.,
San Francisco, CA, USA). pcDNA3.1Neto1HA was a kind gift from
Drs R.R. McInnes (McGill University, Montreal, Canada) and M.W.
Salter (University of Toronto, Toronto, Canada) and pCISGluN2A
1-877 a kind gift of Professor G Hardingham (University of
Edinburgh).
Anti-GluN1 C2, anti-GluN2A (44–58), anti-GluN2A (1381–
1394), anti-GluN2B (46–60) and anti-APP (679–695) antibodies
were raised, generated and afﬁnity-puriﬁed as previously described
(Chazot et al. 1992; Hawkins et al. 1999; Groc et al. 2006; Cousins
et al. 2009). Anti-Neto1 (447-533) antibodies were as in Chow et al.
(2004) and were a kind gift from Drs R.R. McInnes (McGill
University) and M. W. Salter (University of Toronto). Anti-HA and
anti-synapse-associated protein 102 (SAP102) antibodies were from
Abcam (Cambridge, UK); anti-FLAG M2 antibodies were from
Sigma-Aldrich (Dorset, UK). Anti-GluN2B antibodies which were
raised from a 30 kDa GluN2B C-terminal fusion protein were from
Millipore (Billerica, MA, USA). Anti-His antibodies were from Life
Technologies Ltd (Paisley, Scotland).
Generation of GluN1/GluN2A NMDA receptor chimeric subunits
Two sets of GluN1/GluN2A chimeras were generated by overlap
extension PCR. For the ﬁrst set, the respective N-terminal regions
were swapped such that (GluN1)/GluN2A contained GluN1 1-561
followed by GluN2A 557-1464 and (GluN2A)GluN1 contained
GluN2A 1-556 followed by GluN1 562-938. For the second
set, the extracellular S2 domains of GluN1 and GluN2A were
exchanged. Thus GluN1 (GluN2A S2)/GluN1 contained GluN2A
648-816 and GluN2A (GluN1 S2)/GluN2A contained GluN1
650-812.
Mammalian cell transfections
Human embryonic kidney (HEK) 293 cells were transfected using
the calcium phosphate method as described (Cik et al. 1993). For
double transfections where one clone was Neto1, 10 lg DNA were
used at a 1 : 1 ratio, for example, 5 lg Neto1HA: 5 lg GluN1. For
triple transfections a total of 20 lg DNA was used with a ratio of
1 : 3 GluN1 : GluN2A (10 lg total) with 10 lg Neto1HA, 10 lg
APP695FLAG or 10 lg PSD-95ac-Myc. For quadruple transfections, a
total of 30 lg DNA was used with a ratio of 1 : 3 GluN1 : GluN2A
(10 lg total) with 10 lg Neto1HA and 10 lg APP695FLAG. HEK
293 cells expressing GluN1/GluN2 were cultured post-transfection
in the presence of 1 mM ketamine to prevent cell cytotoxicity.
Transfected cells were incubated for 24 h post-transfection and
either assayed for cell surface NMDA receptor expression or they
were harvested and used in immunoprecipitation assays.
Immunoprecipitation assays
Immunoprecipitations were carried out as previously described from
either 1% (v/v) Triton X-100 100 000 g detergent extracts of HEK
293 transfected cells or 1% (w/v) sodium deoxycholate 100 000 g
extracts of adult rat brain (Cousins et al. 2009). Immunoprecipitat-
ing antibodies used were anti-GluN1 C2, anti-GluN2A (1381–
1394), anti-GluN2B (46–60), anti-APP (679–695), anti-His, anti-
HA, anti-FLAG or non-immune Ig antibodies. The resulting
immune pellets were analysed by sodium dodecyl sulphate–
polyacrylamide gel electrophoresis followed by immunoblotting.
Immunoblotting
Immunoblotting was carried out using 7.5% (w/v) polyacrylamide
slab mini-gels all as described previously (Papadakis et al. 2004).
Primary antibodies used were as follows: anti-GluN1 C2; anti-
GluN2A (1381–1394); anti-APP (679–695); anti-Neto1 (447-533),
anti-GluN2B, anti-SAP102, anti-FLAG and anti-HA. Rabbit or
mouse horseradish-linked secondary antibodies were used at a ﬁnal
dilution of 1 : 2000 and immunoreactivities were detected using the
ECL Western blotting system (Amersham Biosciences Ltd., Little
Chalfont, Bucks., UK). Immunoblots with brain tissue used the
above secondary antibodies at a 1 : 10 000 dilution and subsequent
development using the SuperSignal West Femto ECL substrate
(Perbio Science UK Ltd., Northumberland, UK). For all the
immunoblots of the immunoprecipitates, for double transfections,
50% of immune pellets were analysed by the precipitating primary
antibody and 50% with the second different speciﬁcity antibody; for
triple transfections and in brain samples where three different
antibodies were used for immunoblotting of immune pellets, 14% of
the immune pellets were analysed by the precipitating primary
antibody and 42% of the pellets for each of the additional two
speciﬁcity antibodies and for quadruple transfections and in brain
where four different antibodies were used for immunoblotting of
immune pellets, 12% of the immune pellets were analysed by the
precipitating primary antibody, 25% of the pellets for two additional
speciﬁcity antibodies and always 38% for anti-Neto1 activity.
Determination of NMDA receptor cell surface expression by ELISA
The surface expression of GluN1/GluN2A and GluN1/GluN2B
receptors was measured using anti-GluN2A (44–58) and anti-
GluN2B (46–60) antibodies, respectively, since NMDA receptors
are only expressed at the cell surface when they are co-assembled as
© 2013 International Society for Neurochemistry, J. Neurochem. (2013) 126, 554--564
NMDA receptor/APP/Neto1 complexes 555
GluN1/GluN2A or GluN1/GluN2B receptors (McIlhinney et al.
1998). Cell surface ELISA was carried out as previously described
(Papadakis et al. 2004; Cousins et al. 2008).
Analysis of results
All results are the means  SEM and were analysed by the
Student’s two-tailed paired t-test.
Results and Discussion
Neto1HA co-immunoprecipitates with assembled
heteromeric NMDA receptors via GluN2
The association of NMDA receptors with Neto1 is contro-
versial. Ng et al. (2009) reported that anti-Neto1 antibodies
immunoprecipitated GluN1, GluN2A and GluN2B from
radio-immunoprecipitation assay buffer (a buffer containing
the detergents, 1% Non-idet P-40, 0.1% sodium dodecyl
sulfate and 0.5% deoxycholate)-solubilized extracts of syn-
aptosomes. Co-immunoprecipitation was independent of
PSD-95 since all three GluNs co-immunoprecipitated with
a Neto1 construct, Neto1-D20HA, which lacked an intracel-
lular domain and also did not co-immunoprecipitate with
PSD-95 (Ng et al. 2009). In contrast, Straub et al. (2011a, b)
using 1% Triton to solubilize rat brain lysates could not
detect GluN1 or indeed PSD-95 in anti-Neto1 or anti-Neto2
immune pellets thus inferring that since all NMDA receptors
contain GluN1, Neto1 and Neto2 do not associate with
NMDA receptors. To resolve these different observations, we
carried out immunoprecipitations from detergent extracts of
HEK 293 cells transfected with the single clones GluN1,
GluN2A, GluN2B; GluN1/GluN2A and GluN1/GluN2B
binary combinations and 1% sodium deoxycholate extracts
of rat brain. The results are shown in Figs 1–3.
First, for single subunit transfections, Neto1HA was co-
immunoprecipitated by anti-GluN2A and anti-GluN2B but
not anti-GluN1 antibodies indicating, in agreement with Ng
et al. (2009) that Neto1HA associates with GluN2A and
GluN2B subunits (Fig. 1). Since Neto1HA does not associate
with GluN1, in binary transfections, immunoprecipitations
were carried out with anti-GluN1 antibodies thus if Neto1
(a) (b) (c)
Fig. 1 Neto1HA co-associates with GluN2A and GluN2B but not
GluN1 in transfected human embryonic kidney (HEK) 293 cells:
demonstration by co-immunoprecipitation. HEK 293 cells were co-
transfected with the clones:- GluN1 + Neto1HA (a); GluN2A + Neto1HA
(b) and GluN2B + Neto1HA (c). Transfected cell homogenates were
harvested, detergent solubilized, the soluble extracts collected by
centrifugation at 100 000 g, and immunoprecipitated with non-immune
Ig, anti-GluN1 C2 (a), anti-GluN2A (b) or anti-GluN2B (c) antibodies
and immune pellets were analysed by immunoblotting all as described
under Experimental Procedures. The gel lane layout for the immuno-
blots is identical where lane 1 = detergent soluble extract; lane
2 = non-immune pellet and lane 3 = anti-NR1 C2, anti-GluN2A or anti-
GluN2B immune pellet respectively. GluN1, GluN2A, GluN2B and HA
are the antibody speciﬁcities used to probe the immunoblots. ?
denotes GluN1, GluN2A, GluN2B and Neto1HA where appropriate.
The positions of molecular weight standards (9 103 Da) are shown on
the right. The schematic diagrams illustrate the experimental protocol
and the results such that √ = detection in immune pellets and X = no
detection in immune pellets. This key applies for all subsequent
ﬁgures. The immunoblots are representative of at least n = 3
independent immunoprecipitations from n = 3 independent transfec-
tions.
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(a) (b)
Fig. 2 Neto1HA co-associates with assembled GluN1/GluN2A and
GluR1/GluN2B NMDA receptors in transfected human embryonic
kidney (HEK) 293 cells: demonstration by immunoprecipitation with
anti-NR1 C2 antibodies. HEK 293 cells were co-transfected with the
clones:- GluN1 + GluN2A + Neto1HA (a) or GluN1 + GluN2B +
Neto1HA (b). Transfected cell homogenates were harvested, detergent
solubilized, the soluble extracts collected by centrifugation at
100 000 g, and immunoprecipitated with non-immune Ig or anti-NR1
C2 antibodies and immune pellets were analysed by immunoblotting
all as described under Experimental Procedures. The gel lane layout
for the immunoblots is identical where lane 1 = detergent soluble
extract; lane 2 = non-immune pellet and lane 3 = anti-GluN1 C2
immune pellet respectively. GluN1, GluN2A, GluN2B and HA are the
antibody speciﬁcities used to probe the immunoblots. ? denotes
GluN1, GluN2A, GluN2B and Neto1HA where appropriate. The
positions of molecular weight standards (9 103 Da) are shown on
the right. The immunoblots are representative of at least n = 3
independent immunoprecipitations from n = 3 independent transfec-
tions.
(a) (b) (c)
Fig. 3 GluN2A co-immunoprecipitates both amyloid precursor protein
(APP) and Neto1 from detergent extracts of adult mammalian brain.
Detergent extracts (100 000 g) were prepared from adult rat brain,
immunoprecipitations in triplicate carried out using anti-NR2A (1381-
1394) antibodies or non-immune Ig and immune pellets were analysed
by immunoblotting. (a) immunoblotting with anti-GluN2A antibodies; (b)
immunoblotting with anti-APP antibodies and (c) immunoblotting with
anti-Neto1 antibodies. The gel lane layout is identical for each
immunoblot where Input = triplicate samples of detergent soluble
extract; Ig = triplicate non-immune pellets and GluN2A = triplicate
anti-GluN2A (1381-1394) immune pellets. ? denotes GluN2A, APP
and Neto1 where appropriate. The positions of molecular weight
standards (9 103 Da) are shown on the right. The immunoblots are
representative of at least n = 3 independent immunoprecipitations
each carried out in triplicate from at least three separate detergent
extract preparations.
© 2013 International Society for Neurochemistry, J. Neurochem. (2013) 126, 554--564
NMDA receptor/APP/Neto1 complexes 557
and GluN2A or GluN2B were detected in immune pellets, it
must mean that Neto1HA associates with assembled GluN1/
GluN2A and GluN1/GluN2B NMDA receptors. The results
in Fig. 2 show that this is indeed the case with GluN1,
GluN2A or GluN2B and Neto1HA being found in all immune
but not in control, non-immune pellets. Finally, anti-GluN2A
antibodies immunoprecipitated Neto1 from detergent extracts
of rat brain (Fig. 3). Thus, these results concur with those of
Ng et al. (2009) in that at least Neto1 associates with GluN2-
containing NMDA receptors. The differences between the
two original reports may be explained by the detergent
extraction conditions. NMDA receptors are notoriously
difﬁcult to solubilize from native tissue because of their
embedding within the post-synaptic density. It was previ-
ously shown that 1% Triton, the conditions employed by
Straub et al. (2011a, b), solubilizes a pool of unassembled
GluN1 subunits (Chazot and Stephenson 1997) hence the
detection of GluN1 in brain lysates but not in immune pellets
because of the lack of soluble GluN2 subunits. However,
harsher detergent conditions, that is, 1% sodium deoxych-
olate as used here or radio-immunoprecipiation assay buffer
as in Ng et al. (2009) are required to solubilize GluN1/
GluN2 heteromers. Since association with Neto1 is via
GluN2, co-association is only detected in immune pellets
from brain extracts solubilized with these detergents.
It should also be noted that here, immunoprecipitations
were carried out from 100 000 g detergent extracts. Ng et al.
(2009) used a 14 000 g supernatant which is not a bona ﬁde
soluble preparation, nevertheless, our ﬁndings concur.
GluN1/GluN2 assembled NMDA receptors form ternary
complexes with APP and Neto1
To study the possible association of Neto1 with NMDA
receptor/APP complexes ﬁrst, it was investigated if
APP695FLAG could associate with Neto1HA. Both were co-
expressed in HEK 293 cells and immunoprecipitations
carried out using anti-APP antibodies. APP695FLAG was
found in immune pellets but Neto1 was not detected thus
Neto1HA does not co-immunoprecipitate with APP695FLAG
(Fig. 4). To determine if Neto1HA associates with NMDA
receptor/APP695FLAG complexes, GluN1, GluN2A or
GluN2B, APP695FLAG and Neto1HA were co-expressed in
HEK 293 cells and immunoprecipitations carried out with
anti-APP antibodies. Immunoreactivities for all four
expressed proteins were detected in immune but not in
non-immune pellets (Fig. 5). Since APP interacts with only
GluN1; APP does not interact with GluN2 or Neto1 alone;
GluN1 interacts with GluN2 and all four proteins are found
in the immune pellet, it must mean that they are all
co-associated in one macromolecular complex, that is,
APP695FLAG/GluN1/GluN2/Neto1HA (Fig. 5).
To determine if the quaternary complex is found in native
tissue, anti-APP immunoprecipitations were carried out from
detergent extracts of adult rat brain (Fig. 6). GluN2A,
GluN2B and Neto1 immunoreactivities were all detected in
immune but not in control, non-immune pellets thus showing
that all four proteins can be found in one complex. Further,
this is the case for both GluN2A- and GluN2B-containing
NMDA receptors (Fig. 6). Note that the existence of the
APP/GluN1/GluN2/Neto1 quaternary complex is demon-
strated by co-immunoprecipitation, although these experi-
ments show that the four proteins are associated they do not
show that they each interact directly. Association between
different pairs may be because of an intermediary accessory
protein as illustrated in Fig. 5.
The effect of Neto1HA on the surface expression of
NMDA receptors
Wepreviously showed that APP695FLAG enhanced the surface
expression of both GluN1/GluN2A and GluN1/GluN2B
NMDA receptors. Since we showed that APP and Neto1 are
both part of the NMDA receptor macromolecular complex, it
was of interest to determine the effect of Neto1 on NMDA
receptor surface expression and APP695FLAG-enhanced
NMDA receptor surface expression. Thus in parallel, GluN1/
GluN2A and GluN1/GluN2B were both co-expressed with
Fig. 4 Amyloid precursor protein (APP)695FLAG does not co-immuno-
precipitate Neto1HA from transfected human embryonic kidney (HEK)
293 cells. HEK 293 cells were co-transfected with the clones:
APP695FLAG + Neto1HA, transfected cell homogenates harvested,
detergent solubilized, the soluble extracts collected by centrifugation
at 100 000 g and immunoprecipitated with non-immune Ig or anti-APP
antibodies and immune pellets were analysed by immunoblotting all as
described under Experimental Procedures. The gel lane layout for the
immunoblots is identical where lane 1 = detergent soluble extract; lane
2 = non-immune pellet and lane 3 = anti-APP immune pellet respec-
tively. APP and HA are the antibody speciﬁcities used to probe the
immunoblots. ? denotes APP and Neto1HA where appropriate. The
positions of molecular weight standards (9 103 Da) are shown on the
right. The immunoblots are representative of at least n = 3 indepen-
dent immunoprecipitations from n = 3 independent transfections.
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either PSD-95ac-Myc; SAP102c-Myc; APP695FLAG; Neto1HA;
PSD-95ac-Myc + Neto1HA or APP695FLAG + Neto1HA and
surface expressionwas determined 24 h post-transfection. The
results are summarized in Fig. 7.
As previously reported, PSD-95ac-Myc and APP695FLAG
both enhanced GluN1/GluN2A and GluN1/GluN2B surface
expression; SAP102c-Myc had no effect (Rutter et al. 2002;
Cousins et al. 2008, 2009). Interestingly, Neto1HA resulted
in a signiﬁcant decrease in surface expression for both
GluN1/GluN2A (28  5%, n = 13) and GluN1/GluN2B
(30  7%, n = 6) but with no change in total GluN1,
GluN2A or GluN2B expression (Fig. 7). Neto1HA had no
effect on PSD-95ac-Myc- or APP695FLAG-enhanced NMDA
receptor expression (Fig. 7). Ng et al. (2009) reported that
a lack of Neto1 as in Neto1 (/) mice does not alter the
surface expression of GluN2A or GluN2B, rather a
signiﬁcant (~ 30%) decrease in GluN2A in the post-
synaptic density was observed suggesting that Neto1 is
(a) (b)
Fig. 5 APP695FLAG/GluN1/GluN2A/Neto1HA and APP695FLAG/GluN1/
GluN2B/Neto1HA form ternary complexes in transfected human embry-
onic kidney (HEK) 293 cells: demonstration by immunoprecipitation with
anti-APP antibodies. HEK 293 cells were co-transfected with the clones:
GluN1, GluN2A, APP695FLAG and Neto1HA (a) and GluN1, GluN2B,
APP695FLAG and Neto1HA (b), transfected cell homogenates harvested,
detergent solubilized, the soluble extracts collected by centrifugation at
100 000 g and immunoprecipitated with non-immune Ig or anti-APP
antibodies and immune pellets were analysed by immunoblotting all as
described under Experimental Procedures. The gel lane layout for the
immunoblots is identical where lane 1 = detergent soluble extract; lane
2 = non-immune pellet and lane 3 = anti-APP immune pellet respec-
tively. APP, GluN1, GluN2A, GluN2B and HA are the antibody
speciﬁcities used to probe the immunoblots. ? denotes APP, GluN1,
GluN2A, GluN2B and Neto1HA where appropriate. The positions of
molecular weight standards (9 103 Da) are shown on the right. The
immunoblots are representative of at least n = 3 independent immuno-
precipitations from n = 3 independent transfections.
(a) (b) (c) (d)
Fig. 6 APP/GluN2A/Neto1 and APP/GluN2B/Neto1 complexes exist
in the brain: demonstration by immunoprecipitation with anti-APP
antibodies. Detergent extracts (100 000 g) were prepared from adult
rat brain, immunoprecipitations in triplicate carried out using anti-APP
antibodies or non-immune Ig and immune pellets were analysed by
immunoblotting. (a) Immunoblotting with anti-APP antibodies; (b)
immunoblotting with anti-GluN2A antibodies, (c) immunoblotting with
anti-GluN2B antibodies and (d) with anti-Neto1 antibodies. The gel
lane layout is identical for each immunoblot where Input = triplicates
samples of detergent soluble extract; Ig = triplicate non-immune
pellets and APP (671-695) = triplicate anti-APP (1381-1394) immune
pellets. ? denotes APP, GluN2A, GluN2B and Neto1 where appro-
priate. The positions of molecular weight standards (9 103 Da) are
shown on the right. The immunoblots are representative of at least
n = 3 independent immunoprecipitations each carried out in triplicate
from at least three separate detergent extract preparations.
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involved in the targeting and/or stability of GluN2A-
NMDA receptors at synapses. The ﬁndings here show that
Neto1 can inﬂuence surface NMDA receptor expression
although in the presence of PSD-95 as would be the case
in vivo, the Neto1-induced decrease in surface expression
is not apparent. A decrease in receptor cell surface
expression with no change in total overall expression
levels of GluN1, GluN2A and GluN2B subunits suggests
that either Neto1 enhances receptor internalization or it can
decrease receptor insertion into the plasma membrane. The
presence and thus association of assembled GluN1/
GluN2A receptors with PSD-95 may prevent these possi-
bilities.
Intracellular GluN2A C-terminal domains mediate
association of Neto1HA with NMDA receptors
Neto1 is a single transmembrane domain protein compris-
ing of two extracellular CUB domains of ~ 110 amino
acids, a low-density lipoprotein receptor domain class A
motif and a cytoplasmic tail of ~ 167 amino acids that
includes a C-terminal TRV class I PDZ binding motif
(Fig. 8). Ng et al. (2009) showed that removal of the
Neto1 cytoplasmic C-terminal tail and the transmembrane
domain did not abolish Neto1/NMDA receptor interaction.
Further, a Neto1 construct that contained only the signal
sequence and the CUB1 domain retained the ability to
associate with GluN2A; thus, it was concluded that the
(a) (b)
(c) (d)
Fig. 7 Neto1HA decreases surface expression of GluN1/GluN2A and
GluN1/GluN2B receptors. (a and b) Human embryonic kidney (HEK)
293 cells were co-transfected in triplicate in parallel with the clones
shown and cell surface receptor expression was measured 20 h
post-transfection using anti-GluN2A 44-58 Cys or anti-GluN2B 46-60
Cys antibodies as appropriate. The results are expressed as the fold
increase in cell surface expression where the expression of control
transfections, that is, GluNR1/GluN2A/pCIS and GluNR1/GluN2B/
pCIS = 1. Values are the means  SEM for at least the following
independent transfections, n = 13 (GluN1/GluN2A; GluN1/GluN2A/
PSD-95; GluN1/GluN2A/SAP102; GluN1/GluN2A/APP; GluN1/
GluN2A/Neto1); n = 6 (GluN1/GluN2A/PSD-95/Neto1 and GluN1/
GluN2A/APP/Neto1; n = 6 (GluN1/GluN2B; GluN1/GluN2B/PSD-95;
GluN1/GluN2B/SAP102; GluN1/GluN2B/APP; GluN1/GluN2B/Neto1;
GluN1/GluN2A/PSD-95/Neto1 and GluN1/GluN2A/APP/Neto1). (c
and d) HEK 293 cells were co-transfected with GluN1/GluN2A and
GluN1/GluN2B plus the clone indicated on the abscissa, cell
homogenates collected and analysed by quantitative immunoblotting
all as described in Experimental Procedures. The results are
expressed as the fold change in subunit expression, that is, in the
presence divided by in the absence of exogenous APP695FLAG.
Results are the mean  SEM for n = 3 immunoblots from three
independent transfections. *p < 0.025; **p < 0.01; ***p < 0.005;
****p < 0.0005.
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Neto1/NMDA receptor interaction is mediated via the
extracellular Neto1 CUB1 domain. To determine where
within the GluN2A extracellular domain Neto1 binds, a
series of GluN1/GluN2A chimeras were generated, each
was co-expressed with Neto1HA in HEK 293 cells and
immunoprecipitations carried out. For the ﬁrst generation
chimeras, the GluN2A N-terminal LIVBP + the S1 domain
were swapped for the corresponding regions of GluN1 and
vice versa. For the second generation chimeras, GluN2A
S2 was swapped for GluN1S2 domain and vice versa
(Fig. 8). Surprisingly, it was found that replacing the
GluN2A extracellular regions with GluN1 had no effect on
the association with Neto1HA, that is, Neto1HA was always
co-immunoprecipitated with constructs containing the
GluN2A transmembrane and intracellular domains but not
with constructs containing GluN2A extracellular domains
(Fig. 8).
To investigate the association further, GluN1 + Neto1HA
were co-expressed in parallel with a GluN2A C-terminal
truncated construct, that is, GluN2A 1-877; with wild type,
GluN2A and additionally, a tagged construct which encoded
only the GluN2A intracellular domain, that is, GluN2A 838-
1464. The results in Fig. 9 show that deletion of the GluN2A
C-terminal domain results in the loss of co-immunoprecipi-
tating Neto1HA. Conversely, Neto1HA is co-immunoprecip-
tated with GluN2A 838-1464. This implies that it is the
C-terminal GluN2A domain that mediates directly or indi-
rectly, the association with Neto1HA. The reciprocal exper-
iment was carried out whereby the Neto1 C-terminal tail was
deleted 7 amino acids after the transmembrane domain, that
(a) (b) (c)
(d) (e) (f)
Fig. 8 Extracellular GluN2A domains do not mediate association of
Neto1 with NMDA receptors. (a–f) Clones encoding the depicted
GluN1/GluN2 chimeras were generated as shown. Each clone was co-
transfected with Neto1HA, transfected cell homogenates harvested,
detergent solubilized, the soluble extracts collected by centrifugation at
100 000 g and immunoprecipitated with non-immune Ig or anti-GluN1
C2 or GluN2A (1381-1394) antibodies and immune pellets were
analysed by immunoblotting all as described under Experimental
Procedures. GluN1, GluN2A and HA are the antibody speciﬁcities
used to probe the immunoblots.? denotes the respective chimera and
Neto1HA where appropriate. The immunoblots are representative of at
least n = 3 independent immunoprecipitations from n = 3 independent
transfections.
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is, Neto1 1 -372. Surprisingly, anti-FLAG immunoreactivity,
that is, Neto1, was found in immune pellets for Neto1 1-372
co-expressed with full length GluN2A (Fig. 9).
As described above, Ng et al. (2009) found that Neto1
immunoprecipitates with PSD-95. SAP102 is a closely
related scaffold protein that is endogenously expressed in
HEK 293 cells (Sans et al. 2003; Lin et al. 2004). To
investigate the possibility that it is SAP102 that mediates
association with Neto1HA, Neto1HA was expressed alone in
HEK 293 cells, immunoprecipitated and the immune pellet
screened for Neto1HA and SAP102 immunoreactivity
(Fig. 10). For these experiments, the sensitivity of the
immunoblots was increased by using the SuperSignal West
Femto ECL substrate and also analysing 80% of the immune
pellet for SAP102. Under these conditions, SAP102 was
detected in immune but not in control non-immune pellets
(Fig. 10). Simultaneously, the GluN2A 1-877 truncation
construct was co-expressed with GluN1 and SAP102; it was
found that GluN2A 1-877 did not co-immunoprecipitate
SAP102. Thus, there is a correlation between the capability
of GluN2A to co-immunoprecipitate SAP102 and Neto1HA.
However, SAP102 does not co-immunoprecipitate with
Neto1FLAG 1-372 suggesting that GluN2A/Neto1 association
is not mediated via SAP102.
Concluding comments
In this article, we have identiﬁed a new player in the
NMDA receptor/APP trafﬁcking complexes. We have
shown that Neto1 co-immunopreciptates with NMDA
receptor/APP trafﬁcking complexes via association with
GluN2, in heterologous expression and in native brain
tissue. Furthermore, we have shown that it is the GluN2A
C-terminal domain that mediates Neto1 association. The
(a) (b)
(d) (e)
(c)
Fig. 9 The GluN2A intracellular C-terminal domain mediates associ-
ation with Neto1. Transfections were carried out using the clones
encoding Neto1HA alone or, GluN1/GluN2, GluN1/GluN2A 1-877 and
GluN2A 838-1464 with Neto1HA, or, with GluN2A/Neto1FLAG and
GluN2A/Neto1FLAG 1-372 clones as depicted (a–e). Cell homogenates
were harvested, detergent solubilized, the soluble extracts collected by
centrifugation at 100 000 g and immunoprecipitated with non-immune
Ig, anti-GluN1 C2, anti-His or anti-GluN2A antibodies and immune
pellets were analysed by immunoblotting all as described under
Experimental Procedures. GluN1, GluN2A, His and FLAG are the
antibody speciﬁcities used to probe the immunoblots The immunoblots
are representative of at least n = 3 independent immunoprecipitations
from n = 3 independent transfections.
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original work of Ng et al. (2009) showed that Neto1
associated with assembled NMDA receptors via GluN2A
and the Neto1 extracellular N-terminal CUB1 domain. We
conclude that Neto1 associates with NMDA receptors via
GluN2; however, our ﬁndings are difﬁcult to reconcile with a
direct association between GluN2 and Neto1 since the
removal of the GluN2A extracellular domain has no effect
on GluN2A/Neto1 co-immunoprecipitation. Rather, we dem-
onstrate that it is the intracellular region of GluN2A that
mediates association. Further, since Ng et al. (2009) showed
that deletion of the C-terminal 20 amino acids of Neto1 and
the results presented here which deleted a further 141 amino
acids from the Neto1 intracellular domain showed that these
truncated constructs retained the ability to co-immunopre-
cipitate with GluN2A, it is hard to visualize how association
between the two proteins could be direct. Since it is
endogenously expressed in HEK cells, SAP102 is a potential
candidate for an intermediary protein since it co-immuno-
precipitates with both Neto1 and GluN2A. However,
SAP102 does not co-immunoprecipitate with Neto1FLAG 1-
372 and thus such a possibility is excluded. Overall, these
ﬁndings suggest that Neto1 is not an NMDA receptor
auxillary subunit since the protein–protein interactions that
we have determined imply that their association is indirect.
Nevertheless, a new player in NMDA receptor/APP
trafﬁcking complexes has been identiﬁed. Future studies
will ascertain how APP and Neto1 interactions regulate the
appropriate surface expression of this key neurotransmitter
receptor.
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antibodies and immune pellets were analysed by immunoblotting all as
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SAP102 and FLAG are the antibody speciﬁcities used to probe
the immunoblots. The immunoblots are representative of at least
n = 3 independent immunoprecipitations from n = 3 independent
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